Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$1.66 - $3.67 $28,457 - $62,914
-17,143 Reduced 6.73%
237,575 $418,000
Q4 2022

Feb 14, 2023

BUY
$2.77 - $5.07 $356,715 - $652,904
128,778 Added 102.25%
254,718 $799,000
Q3 2022

Nov 14, 2022

SELL
$4.27 - $6.39 $28,301 - $42,352
-6,628 Reduced 5.0%
125,940 $617,000
Q2 2022

Aug 15, 2022

SELL
$3.28 - $6.21 $73,576 - $139,302
-22,432 Reduced 14.47%
132,568 $549,000
Q1 2021

May 17, 2021

SELL
$10.88 - $17.05 $115,328 - $180,730
-10,600 Reduced 6.4%
155,000 $1.94 Million
Q4 2020

Feb 03, 2021

SELL
$9.23 - $18.18 $190,138 - $374,508
-20,600 Reduced 11.06%
165,600 $2.58 Million
Q3 2020

Nov 16, 2020

BUY
$9.38 - $12.48 $75,040 - $99,840
8,000 Added 4.49%
186,200 $1.76 Million
Q2 2020

Aug 12, 2020

BUY
$6.21 - $11.83 $5,589 - $10,647
900 Added 0.51%
178,200 $1.6 Million
Q1 2020

May 06, 2020

BUY
$5.05 - $8.85 $27,775 - $48,675
5,500 Added 3.2%
177,300 $1.13 Million
Q3 2019

Nov 12, 2019

BUY
$9.05 - $12.22 $221,725 - $299,390
24,500 Added 16.63%
171,800 $1.56 Million
Q2 2019

Aug 14, 2019

SELL
$8.75 - $13.03 $440,125 - $655,409
-50,300 Reduced 25.46%
147,300 $1.59 Million
Q1 2019

May 13, 2019

BUY
$7.72 - $12.81 $716,416 - $1.19 Million
92,800 Added 88.55%
197,600 $1.89 Million
Q4 2018

Feb 11, 2019

BUY
$9.51 - $16.6 $14,265 - $24,900
1,500 Added 1.45%
104,800 $1.2 Million
Q2 2018

Aug 03, 2018

BUY
$13.9 - $19.8 $279,390 - $397,980
20,100 Added 24.16%
103,300 $1.47 Million
Q4 2017

Feb 08, 2018

BUY
$11.6 - $17.35 $350,320 - $523,970
30,200 Added 56.98%
83,200 $1.36 Million
Q3 2017

Nov 01, 2017

BUY
$8.4 - $15.0 $445,200 - $795,000
53,000
53,000 $795,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $50.1M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.